Immunic
IMUX
$1.19
Share price
1.83%
Change (1 day)
-37.33%
Change (1 year)
Categories
Earnings for Immunic (IMUX)
Earnings in 2024 (TTM): -S$0.14 Billion
According to Immunic's latest financial reports the company's current earnings are N/A. , an increase over its 2023 earnings that were of -S$0.14 Billion. The earnings displayed on this page is the company's Pretax Income.
Earnings history for Immunic from 2013 to 2024
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2024  | -S$0.13 Billion | -1.18% |
| 2023 | -S$0.14 Billion | 14.68% |
| 2022 | -S$0.12 Billion | -5.62% |
| 2021 | -S$0.13 Billion | 87.18% |
| 2020 | -S$64.58 Million | 32.24% |
| 2019 | -S$48.84 Million | -9.25% |
| 2018 | -S$53.81 Million | -22.5% |
| 2017 | -S$69.44 Million | 27.6% |
| 2016 | -S$54.42 Million | -20.82% |
| 2015 | -S$68.73 Million | 9.34% |
| 2014 | -S$62.86 Million | 33.05% |
| 2013 | -S$47.24 Million |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 | -S$0.19 Billion | 45.73% | 🇺🇸 USA |